Business Insider’s biggest healthcare stories for October 19

Welcome to Business Insiders daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Pills 2 (2)



Hollis Johnson/Business Insider


Hello,

Today in healthcare news: The pitch deck that convinced J&J to bet on a new kind of healthcare company, Pfizer plans to submit its vaccine in November for emergency authorization if it works, and an inside look at how Gilead developed remdesivir, a drug that now faces questions about how effective it is in treating COVID-19. 


Demetri (L) _ Steven (R)

Keeps co-founders Demetri Karagas and Steven Gutentag

Courtesy Keeps


See the pitch deck 2 former Googlers used to raise $47 million and convince Johnson & Johnson to bet on the hottest part of healthcare

Read the full story from Blake Dodge here>>


Jab injection vaccine



Xinhua/Gil Cohen Magen via Getty Images


Pfizer plans to submit its COVID-19 vaccine for FDA authorization in late November — if human trials show it works

Read the full story from Grace Dean here>>


Gilead Sciences Coronavirus Remdesivir Biotech Lab

Lab technicians operate a machine to wash empty vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 18, 2020.

Gilead Sciences Inc/Handout via Reuters


Here’s how the biotech giant Gilead created the leading coronavirus drug remdesivir, which now faces questions over its effectiveness at treating COVID-19

Read the full story here>>


More stories we’re reading: 


Subscribe to this newsletter here. 

– Lydia

LoadingSomething is loading.

source.



LuvNaughty | We're here to get you off LiL VAPE | Home of the vapour Latest Media News | Stay updated with us The Lazy Days | Procrastinate right